147 related articles for article (PubMed ID: 7348574)
1. Oestrogen receptor concentration in primary breast cancer and axillary node metastases.
Hawkins RA; Black R; Steele RJ; Dixon JM; Forrest AP
Breast Cancer Res Treat; 1981; 1(3):245-51. PubMed ID: 7348574
[TBL] [Abstract][Full Text] [Related]
2. [Relation of steroid hormone receptors to axillary lymph node metastasis in breast carcinoma].
Etzrodt A; Jung H; Schweissfurth C; Tolxdorff T; Lamberti G
Geburtshilfe Frauenheilkd; 1983 Dec; 43(12):726-31. PubMed ID: 6559147
[TBL] [Abstract][Full Text] [Related]
3. Morphometry and breast cancer. II. Characterisation of breast cancer cells with high malignant potential in patients with spread to lymph nodes: preliminary results.
van der Linden HC; Baak JP; Lindeman J; Hermans J; Meyer CJ
J Clin Pathol; 1986 Jun; 39(6):603-9. PubMed ID: 3722413
[TBL] [Abstract][Full Text] [Related]
4. Distribution of estrogen and progesterone receptors in primary tumor and lymph nodes in individual patients with breast cancer.
Coradini D; Cappelletti V; Miodini P; Ronchi E; Scavone G; Di Fronzo G
Tumori; 1984 Apr; 70(2):165-8. PubMed ID: 6730015
[TBL] [Abstract][Full Text] [Related]
5. Estrogen and progesterone receptor assays on breast carcinoma from mastectomy specimens.
Meyer JS; Schechtman K; Valdes R
Cancer; 1983 Dec; 52(11):2139-43. PubMed ID: 6627219
[TBL] [Abstract][Full Text] [Related]
6. Primary tumour characteristics and axillary lymph node status in breast cancer.
Yiangou C; Shousha S; Sinnett HD
Br J Cancer; 1999 Aug; 80(12):1974-8. PubMed ID: 10471048
[TBL] [Abstract][Full Text] [Related]
7. [Long-term study of the significance of hormone receptors as prognostic factors in breast cancer].
Merkle E; Seidl I; Bähr I; Tulusan AH; von Maillot K; Sauerbrei KW; Wirtz PM
Geburtshilfe Frauenheilkd; 1990 Jul; 50(7):528-32. PubMed ID: 2391019
[TBL] [Abstract][Full Text] [Related]
8. Biomarker expression and St Gallen molecular subtype classification in primary tumours, synchronous lymph node metastases and asynchronous relapses in primary breast cancer patients with 10 years' follow-up.
Falck AK; Bendahl PO; Chebil G; Olsson H; Fernö M; Rydén L
Breast Cancer Res Treat; 2013 Jul; 140(1):93-104. PubMed ID: 23807420
[TBL] [Abstract][Full Text] [Related]
9. [A new perspective on axillary dissection in situations of metastatic sentinel node].
Zedníková I; Ňaršanská A; Hes O; Metelková A; Fiala O; Svoboda T
Rozhl Chir; 2017; 96(8):346-352. PubMed ID: 29058925
[TBL] [Abstract][Full Text] [Related]
10. Absent progesterone receptor expression in the lymph node metastases of ER-positive, HER2-negative breast cancer is associated with relapse on tamoxifen.
Snell CE; Gough M; Middleton K; Hsieh M; Furnas L; Seidl B; Gibbons K; Pyke C; Shannon C; Woodward N; Armes JE
J Clin Pathol; 2017 Nov; 70(11):954-960. PubMed ID: 28416639
[TBL] [Abstract][Full Text] [Related]
11. Variability of oestrogen and progesterone receptor status between primary breast cancer and nodal metastases: preliminary communication.
Fernandez D; Sauven P; Alaghband-Zadeh J; Burn JI
J R Soc Med; 1982 Sep; 75(9):719-22. PubMed ID: 7120257
[TBL] [Abstract][Full Text] [Related]
12. The effect of tumor size and axillary lymph node metastasis on estrogen and progesterone receptors in primary breast cancer.
Alghanem AA; Hussain S
J Surg Oncol; 1986 Mar; 31(3):218-21. PubMed ID: 3724175
[TBL] [Abstract][Full Text] [Related]
13. Oestrogen receptors and primary breast cancer.
Humeniuk V; Hawkins RA; Prescott RJ; Roberts MM; Stewart HJ; Forrest AP
Aust N Z J Surg; 1982 Aug; 52(4):408-14. PubMed ID: 6956318
[TBL] [Abstract][Full Text] [Related]
14. [Loss of hormonal receptors expression from primary breast carcinoma to axillary lymph node metastases].
Cianga C; Cianga P; Cozma L; Diaconu C; Carasevici E
Rev Med Chir Soc Med Nat Iasi; 2003; 107(3):540-4. PubMed ID: 14756058
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneity of soluble and nuclear oestrogen receptor status of involved nodes in relation to primary breast cancer.
Castagnetta L; Traina A; Di Carlo A; Latteri AM; Carruba G; Leake RE
Eur J Cancer Clin Oncol; 1987 Jan; 23(1):31-5. PubMed ID: 3595683
[TBL] [Abstract][Full Text] [Related]
16. Tumour cellularity, oestrogen receptors and prognosis in breast cancer.
Black R; Prescott R; Bers K; Hawkins A; Stewart H; Forrest P
Clin Oncol; 1983 Dec; 9(4):311-8. PubMed ID: 6661854
[TBL] [Abstract][Full Text] [Related]
17. [Proliferation index, axillary lymph node status, hormone receptors and age as prognostic factors in primary breast cancer].
Kaufmann M; Klinga K; Kühn W; Abel U
Geburtshilfe Frauenheilkd; 1989 Feb; 49 Suppl 1():104-8. PubMed ID: 2703135
[TBL] [Abstract][Full Text] [Related]
18. Oestrogen receptors and prognosis in early breast cancer.
Cooke T; George D; Shields R; Maynard P; Griffiths K
Lancet; 1979 May; 1(8124):995-7. PubMed ID: 86771
[TBL] [Abstract][Full Text] [Related]
19. Correlation of DNA flow cytometry and hormone receptors with axillary lymph node status in patients with carcinoma of the breast.
Friedman NS; Freedman MD
Md Med J; 1994 Nov; 43(11):963-5. PubMed ID: 7808198
[TBL] [Abstract][Full Text] [Related]
20. Distribution of estrogen and progesterone receptors on primary tumor and lymph nodes in individual patients with breast cancer.
Klinga K; Kaufmann M; Runnebaum B; Kubli F
Oncology; 1982; 39(6):337-9. PubMed ID: 7133597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
